AbstractCrosspresentation of self-antigens by antigen-presenting cells is critical for the induction of peripheral tolerance. As apoptosis facilitates the entry of antigens into the crosspresentation pathway, we sought to prevent the development of autoimmune diabetes by inducing pancreatic β cell apoptosis before disease onset. Accordingly, young nonobese diabetic (NOD) mice injected with a single low dose of streptozotocin (SZ), a drug cytotoxic for β cells, exhibited impaired T cell responses to islet antigens and were protected from spontaneous diabetes. Furthermore, β cell apoptosis was necessary for protection since SZ did not protect RIP-CrmA transgenic NOD mice in which β cells expressed the caspase inhibitor CrmA. Our results suppo...
Apoptosis is known as a major mechanism which contributes to beta cell decay in type 1 diabetes. Com...
Type 1 diabetes (T1D) results from autoimmune destruction of insulin-producing pancreatic β cells. T...
The past decade has seen a significant increase in the number of potentially tolerogenic therapies f...
CTLs are important mediators of pancreatic β cell destruction in the nonobese diabetic mouse model o...
© 2016 Dr. Gaurang JhalaImmune responses to proinsulin initiate anti-islet autoimmunity in non-obese...
The NOD/Lt mouse, a widely used model of human autoimmune IDDM, was used to establish the mode of β-...
Insulin-dependent Type 1 diabetes (T1D) is a devastating autoimmune disease that destroys beta cells...
Insulin-dependent Type 1 diabetes (T1D) is a devastating autoimmune disease that destroys beta cells...
Increasing pancreatic β-cell proliferation in autoimmune type 1 diabetes (T1D) might restore β-cell ...
Increasing pancreatic β-cell proliferation in autoimmune type 1 diabetes (T1D) might restore β-cell ...
Increasing pancreatic β-cell proliferation in autoimmune type 1 diabetes (T1D) might restore β-cell ...
Apoptosis is known as a major mechanism which contributes to beta cell decay in type 1 diabetes. Com...
Type 1 diabetes (T1D) results from autoimmune destruction of insulin-producing pancreatic β cells. T...
Type 1 diabetes (T1D) results from autoimmune destruction of insulin-producing pancreatic β cells. T...
Insulin-dependent Type 1 diabetes (T1D) is a devastating autoimmune disease that destroys beta cells...
Apoptosis is known as a major mechanism which contributes to beta cell decay in type 1 diabetes. Com...
Type 1 diabetes (T1D) results from autoimmune destruction of insulin-producing pancreatic β cells. T...
The past decade has seen a significant increase in the number of potentially tolerogenic therapies f...
CTLs are important mediators of pancreatic β cell destruction in the nonobese diabetic mouse model o...
© 2016 Dr. Gaurang JhalaImmune responses to proinsulin initiate anti-islet autoimmunity in non-obese...
The NOD/Lt mouse, a widely used model of human autoimmune IDDM, was used to establish the mode of β-...
Insulin-dependent Type 1 diabetes (T1D) is a devastating autoimmune disease that destroys beta cells...
Insulin-dependent Type 1 diabetes (T1D) is a devastating autoimmune disease that destroys beta cells...
Increasing pancreatic β-cell proliferation in autoimmune type 1 diabetes (T1D) might restore β-cell ...
Increasing pancreatic β-cell proliferation in autoimmune type 1 diabetes (T1D) might restore β-cell ...
Increasing pancreatic β-cell proliferation in autoimmune type 1 diabetes (T1D) might restore β-cell ...
Apoptosis is known as a major mechanism which contributes to beta cell decay in type 1 diabetes. Com...
Type 1 diabetes (T1D) results from autoimmune destruction of insulin-producing pancreatic β cells. T...
Type 1 diabetes (T1D) results from autoimmune destruction of insulin-producing pancreatic β cells. T...
Insulin-dependent Type 1 diabetes (T1D) is a devastating autoimmune disease that destroys beta cells...
Apoptosis is known as a major mechanism which contributes to beta cell decay in type 1 diabetes. Com...
Type 1 diabetes (T1D) results from autoimmune destruction of insulin-producing pancreatic β cells. T...
The past decade has seen a significant increase in the number of potentially tolerogenic therapies f...